Skip to main content
SpringerLink
Log in

Bevacizumab/ranibizumab

Arterial thromboembolic events following intravitreal administration in elderly patients: 15 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Carneiro AM, Barthelmes D, Falcao MS, Mendonca LS, Fonseca SL, Goncalves RM, Faria-Correia F, Falcao-Reis FM.Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. Ophthalmologica 225: 211-221, No. 4, Apr 2011. Available from: URL: http://dx.doi.org/10.1159/000323943 - Portugal

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/ranibizumab. React. Wkly. 1355, 11 (2011). https://doi.org/10.2165/00128415-201113550-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113550-00034

Keywords

Search

Navigation